Liu F, Yan T, Cui D, Jiang J
Sci Rep. 2024; 14(1):15633.
PMID: 38972883
PMC: 11228042.
DOI: 10.1038/s41598-024-66610-z.
Shimizu A, Kubota K, Notake T, Kitagawa N, Masuo H, Yoshizawa T
J Hepatobiliary Pancreat Sci. 2024; 31(8):513-527.
PMID: 38803276
PMC: 11503460.
DOI: 10.1002/jhbp.12004.
Li Y, Wei S, Fu Y, Zeng Z, Huang L, Lv J
Front Oncol. 2024; 14:1372123.
PMID: 38628666
PMC: 11018934.
DOI: 10.3389/fonc.2024.1372123.
Kim J, Jeong W, Kim J, Ha S, Kim K
Abdom Radiol (NY). 2023; 49(2):437-446.
PMID: 37989897
DOI: 10.1007/s00261-023-04106-6.
Wang D, Xiao M, Wan Z, Lin X, Li Q, Zheng S
World J Gastrointest Surg. 2023; 15(4):544-552.
PMID: 37206072
PMC: 10190723.
DOI: 10.4240/wjgs.v15.i4.544.
Physics-based tissue simulator to model multicellular systems: A study of liver regeneration and hepatocellular carcinoma recurrence.
Luque L, Carlevaro C, Llamoza Torres C, Lomba E
PLoS Comput Biol. 2023; 19(3):e1010920.
PMID: 36877741
PMC: 10019748.
DOI: 10.1371/journal.pcbi.1010920.
Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center.
Penzkofer L, Groger L, Hoppe-Lotichius M, Baumgart J, Heinrich S, Mittler J
Cancers (Basel). 2023; 15(3).
PMID: 36765596
PMC: 9913586.
DOI: 10.3390/cancers15030639.
Reversal of TGF-β-induced epithelial-mesenchymal transition in hepatocellular carcinoma by sorafenib, a VEGFR-2 and Raf kinase inhibitor.
Modi S, Tiwari A, Kulkarni V
Curr Res Pharmacol Drug Discov. 2021; 2:100014.
PMID: 34909649
PMC: 8663974.
DOI: 10.1016/j.crphar.2021.100014.
Different Risk Factors for Early and Late Recurrence After Curative Resection of Hepatocellular Carcinoma.
Hong S, Jin X, Suh S, Hong S, Hong K, Han E
World J Surg. 2021; 46(1):197-206.
PMID: 34533588
DOI: 10.1007/s00268-021-06308-9.
Indication of Surgical Hepatectomy for the Patients of Hepatocellular Carcinoma with Inferior Vena Cava Tumor Thrombosis.
Nishizawa Y, Kuramitsu K, Kido M, Komatsu S, Gon H, Urade T
Kobe J Med Sci. 2021; 67(1):E10-E17.
PMID: 34344853
PMC: 8622260.
Anatomical resection is useful for the treatment of primary solitary hepatocellular carcinoma with predicted microscopic vessel invasion and/or intrahepatic metastasis.
Okamura Y, Sugiura T, Ito T, Yamamoto Y, Ashida R, Ohgi K
Surg Today. 2021; 51(9):1429-1439.
PMID: 33564928
DOI: 10.1007/s00595-021-02237-1.
Outcomes of resection for hepatocellular carcinoma with macroscopic bile duct tumour thrombus: A propensity score matched study.
Chi Q, Shi Z, Zhang Z, Zhang X, Zhang L, Weng S
Oncol Lett. 2020; 20(4):118.
PMID: 32863931
PMC: 7448567.
DOI: 10.3892/ol.2020.11979.
Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.
Michelakos T, Kontos F, Sekigami Y, Qadan M, Cai L, Catalano O
J Gastrointest Surg. 2020; 25(7):1727-1735.
PMID: 32779082
DOI: 10.1007/s11605-020-04765-6.
Homotypic cell membrane-cloaked biomimetic nanocarrier for the accurate photothermal-chemotherapy treatment of recurrent hepatocellular carcinoma.
Sun Y, Zhai W, Liu X, Song X, Gao X, Xu K
J Nanobiotechnology. 2020; 18(1):60.
PMID: 32299505
PMC: 7164213.
DOI: 10.1186/s12951-020-00617-2.
Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma.
Yeoh K, Prawira A, Saad M, Lee K, Lee E, Low G
Cancers (Basel). 2020; 12(4).
PMID: 32260169
PMC: 7226273.
DOI: 10.3390/cancers12040872.
Is It Just a Matter of Surgical Extension to Achieve the Cure of Hepatocarcinoma? A Meta-Analysis of Propensity-Matched and Randomized Studies for Anatomic Versus Parenchyma-Sparing Liver Resection.
Famularo S, Ceresoli M, Giani A, Ciulli C, Pinotti E, Romano F
J Gastrointest Surg. 2020; 25(1):94-103.
PMID: 31898106
DOI: 10.1007/s11605-019-04494-5.
Repeat liver resection versus salvage liver transplant for recurrent hepatocellular carcinoma: A propensity score-adjusted and -matched comparison analysis.
Guo Y, Tan E, Syn N, Krishnamoorthy T, Tan C, Lim R
Ann Hepatobiliary Pancreat Surg. 2019; 23(4):305-312.
PMID: 31824994
PMC: 6893044.
DOI: 10.14701/ahbps.2019.23.4.305.
Effect of prophylactic TACE on 5-year survival of patients with hepatocellular carcinoma after hepatectomy.
He S, Fan X, Ma H, Xiaerfuhazi H, Rehato A, Feng J
Oncol Lett. 2019; 18(2):1824-1830.
PMID: 31423250
PMC: 6614664.
DOI: 10.3892/ol.2019.10517.
BDH2 is downregulated in hepatocellular carcinoma and acts as a tumor suppressor regulating cell apoptosis and autophagy.
Liang H, Xiong Z, Li R, Hu K, Cao M, Yang J
J Cancer. 2019; 10(16):3735-3745.
PMID: 31333791
PMC: 6636298.
DOI: 10.7150/jca.32022.
Follow-Up Liver Stiffness Measurements after Liver Resection Influence Oncologic Outcomes of Hepatitis-B-Associated Hepatocellular Carcinoma with Liver Cirrhosis.
Lee J, Lee H, Kim S, Ahn S, Lee K
Cancers (Basel). 2019; 11(3).
PMID: 30934621
PMC: 6468874.
DOI: 10.3390/cancers11030425.